Hospital Utilization for Coronary Artery Disease, 1997-2014

Insights

Hospitalizations for coronary artery disease (CAD) increased, with higher costs and death rates from 1997-2014. Older adults and urban patients incurred greater charges, highlighting disparities in care for this leading cardiovascular condition.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Public Health Policy

Background:

  • Coronary artery disease (CAD) is a major cause of illness, death, and healthcare expenses in the U.S.
  • Limited research exists on the impact of public health and payment reforms on inpatient care for CAD patients.
  • Understanding trends in hospital utilization is crucial for managing CAD's burden.

Purpose of the Study:

  • To analyze trends in hospital discharges, charges, and discharge destinations for patients with CAD.
  • To examine these trends over a significant period (1997-2014) using national data.
  • To identify demographic and geographic factors influencing inpatient care patterns for CAD.

Main Methods:

  • Longitudinal study design.
  • Descriptive analysis of the Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) data.
  • Analysis of over 1.3 million patient discharges.

Main Results:

  • A total of 1,333,996 discharges were analyzed.
  • Patients aged 65-84 were highest users, followed by the 45-64 age group.
  • The death rate rose from 5961 to 7217 per 10,000 patients.
  • Mean hospital charges increased over fivefold, from $9,100 to $49,643.
  • Urban hospital charges ($51,666) were substantially higher than rural ($25,548) in 2014.
  • Patients with private insurance had higher mean charges than those with Medicaid/Medicare.
  • Discharges to home and associated healthcare costs increased by 4.1% and 4.8%, respectively.

Conclusions:

  • Future research should utilize comprehensive datasets like Medicare claims to understand patient-level factors in CAD inpatient care.
  • Enhanced cardiac rehabilitation and patient education are vital in post-hospital settings for CAD patients.
  • Addressing disparities in care based on location and insurance type is necessary.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
14
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46